ArticleTranslational andrology and urology2024
Validity and utility of switch-maintenance therapy with nivolumab in tyrosine kinase inhibitor-sensitive patients with metastatic renal cell carcinoma: learning from NIVOSWITCH.
Taigo Kato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.